Homology Medicines, Inc. (FIXX) Misses Q3 EPS by 14c

Homology Medicines, Inc. (NASDAQ: FIXX) reported Q3 EPS of ($0.57), $0.14 worse than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Homology Medicines, Inc. (FIXX) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance